Bacterial components‐driven intrahepatic CXCR5 hi B cells are important population for MASH progression through inducing inflammation
- 15 January 2025
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 39 (2) , e70322
Abstract
Metabolic dysfunction‐associated steatohepatitis (MASH) is characterized by severe liver inflammation and fibrosis due to an imbalanced immune response caused by enhanced bacterial components. The progression of MASH is closely linked to increased permeability of intestinal mucosal barrier facilitating enter of bacterial components into hepatic portal venous system. B cells are important immune cells for adaptive responses and enhance hepatic inflammation through cytokine production and T cell activation. B cells are influenced by gut microbiota, but the specific B cell populations in MASH and their pathologic mechanism remain obscure. Here, we found that the numbers of B cells highly expressing CXCR5, the receptor of CXCL13 chemokine, were increased in the livers of MASH. CXCR5 high B cells are non‐proliferating naive B cells with inflammatory features mainly residing in hepatic parenchyma to affect liver pathology. Importantly, we revealed that CXCR5 high B cells were induced by bacterial components stimulating TLRs. These bacterial stimulator‐induced CXCR5 hi B cells highly express TNFα, CD80, and MHC class II, leading to T cell activation. Consistently, we confirmed that intravenous injection of CXCR5 high B cells enhanced hepatic inflammation in MASH model. Ultimately, this study elucidates the role and mechanisms of CXCR5 high B cells in advancing MASH progression.Keywords
Funding Information
- National Research Foundation of Korea (RS‐2024‐00338402, RS‐2023‐00301850, 2022R1A6C101A739, RS‐2024‐00439637)
This publication has 43 references indexed in Scilit:
- Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5–CD19low B Cells in Systemic Lupus ErythematosusArthritis & Rheumatology, 2022
- Dual roles of B lymphocytes in mouse models of diet‐induced nonalcoholic fatty liver diseaseHepatology, 2022
- The Emerging Role of B Cells in the Pathogenesis of NAFLDHepatology, 2021
- Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive SignalingHepatology, 2021
- B Cell Responses: Cell Interaction Dynamics and DecisionsCell, 2019
- B lymphocytes limit senescence‐driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injuryHepatology, 2018
- Pretreatment of Pam3CSK4 attenuates inflammatory responses caused by systemic infection of methicillin-resistant Staphylococcus aureus in miceBiomedicine & Pharmacotherapy, 2017
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†Hepatology, 2009
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivityEuropean Journal of Immunology, 1998